Reassessing The Changing Outlook For Recursion Pharmaceuticals Inc (RXRX)
Currently, there are 226.26M common shares owned by the public and among those 221.54M shares have been available to trade. The company’s stock has a 5-day price change of -22.19% and -14.80% over the past three months. RXRX shares are trading -38.13% year to date (YTD), with the 12-month market performance down to -8.55% lower. […]
These Numbers Could Change Investor Views For Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 226.26M common shares owned by the public and among those 223.17M shares have been available to trade. The company’s stock has a 5-day price change of 18.07% and 19.88% over the past three months. RXRX shares are trading -20.49% year to date (YTD), with the 12-month market performance up to 49.90% higher. […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
Currently, there are 291.36M common shares owned by the public and among those 226.84M shares have been available to trade. The company’s stock has a 5-day price change of 1.19% and 7.06% over the past three months. RXRX shares are trading -30.83% year to date (YTD), with the 12-month market performance up to 15.40% higher. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): To Buy Or Not To Buy, That Is The Question
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Wednesday at a closing price of $6.68, with 4.46 million shares of worth about $29.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.90% during that period and on October 30, 2024 the price saw a […]
Investors Should Take Note Of Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Wednesday at a closing price of $6.33, with 3.96 million shares of worth about $25.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.28% during that period and on October 23, 2024 the price saw a […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Do Not Miss The Gain Train
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Wednesday at a closing price of $7.01, with 4.51 million shares of worth about $31.65 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.16% during that period and on October 16, 2024 the price saw a […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Loses -59.09% From High. Why That Could Change?
Currently, there are 226.26M common shares owned by the public and among those 222.95M shares have been available to trade. The company’s stock has a 5-day price change of 4.38% and -10.93% over the past three months. RXRX shares are trading -34.69% year to date (YTD), with the 12-month market performance down to -8.39% lower. […]
Recursion Pharmaceuticals Inc (RXRX): Street Finally Waking Up
Currently, there are 226.26M common shares owned by the public and among those 222.94M shares have been available to trade. The company’s stock has a 5-day price change of -9.80% and -13.83% over the past three months. RXRX shares are trading -37.42% year to date (YTD), with the 12-month market performance down to -19.35% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Stock In Prove Me State
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Thursday at a closing price of $6.89, with 3.25 million shares of worth about $22.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.24% during that period and on September 25, 2024 the price saw a […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 183.21M common shares owned by the public and among those 146.52M shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 56 of these insider trades were purchases, […]
